SLNO vs VTRS · P/E 27, $2.76B cap vs rev $7.27B
Soleno Therapeutics Inc (SLNO) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
SLNO does not have a complete income-statement cache yet.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
SLNO currently screens at market cap $2.76B and trailing P/E 27.5. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the SLNO and VTRS stock pages for the full models.
Not investment advice.